Nukacin ISK-1 is a type-A(II) lantibiotic produced by Staphylococcus warneri ISK-1. In this study, we characterized NukM and NukT, which are predicted to be involved in modification of prepeptide (NukA) and cleavage of leader peptide and subsequent secretion respectively. Localization analysis of NukM and NukT in the wild-type strain indicated that both proteins were located at the cytoplasm membrane. Interestingly, NukM expressed heterologously in St. carnosus TM300 was also located at the cytoplasm membrane even in the absence of NukT. Yeast two-hybrid assay showed that a complex of at least two each of NukM and NukT was associated with NukA. In vitro interaction analysis by surface plasmon resonance biosensor further suggested that membrane-located NukM interacted with NukA. These results indicate that NukM and NukT form a membrane-located multimeric protein complex and that post-translational modification of nukacin ISK-1 would occur at the cytoplasm membrane.
Bacteriocins are proteinaceous antimicrobial substances produced by certain microorganisms and classified into certain classes. Lantibiotics are class I bacteriocins that are antimicrobial peptides containing unusual amino acids such as dehydrated and lanthionine residues. The genes for lantibiotic biosynthesis are clustered and have been designated by generic symbol lan. Lantibiotics are synthesized on ribosomes as prepeptides (LanA). These prepeptides undergo several post-translational modification events to form biologically active peptides. 1, 2) According to de Vos et al., 1) linear lantibiotics (type-A) are divided into two subtypes, type-A(I) and type-A(II). In type-A(I) lantibiotics, LanB and LanC are proposed to catalyze the unusual amino acid formation of prepeptides. [3] [4] [5] The ABC transporter LanT secretes the modified prepeptides and LanP cleaves off the leader peptide outside the cellular membrane. 6) In contrast to type-A(I) lantibiotics, the gene clusters of type-A(II) lantibiotics contain lanM instead of lanB and lanC. 7, 8) In addition, a dual-functional ABC transporter LanT probably cleaves off the leader peptides inside the cellular membrane and secretes the mature peptides to the outside. 9) Hence, it is assumed that the biosynthetic mechanisms of the two types of lantibiotics are different.
In the case of the type-A(I) lantibiotics nisin and subtilin, there is evidence that LanB, LanC, and LanT form a lantibiotic synthetase complex on the cellular membrane and that the complex associates with LanA. 10, 11) Recently, it has been found that LctM catalyzes the formation of unusual amino acids in the type-A(II) lantibiotic lacticin 481. 12) Characterization of the modification enzyme might involve generating new compounds with unique properties by the introduction of unusual amino acids. Clarification of the biosynthetic mechanism might also make possible high production of lantibiotics.
Staphylococcus warneri ISK-1 was isolated from a well-aged Nukadoko, a bed of fermented rice bran. 13) This bacterium produces a type-A(II) lantibiotic, nukacin ISK-1. 14, 15) The biosynthetic gene cluster of nukacin ISK-1 encoded in plasmid has been sequenced. [16] [17] [18] From the sequence similarity with known proteins involved in lantibiotic biosynthesis, NukA, NukM, and NukT were predicted to be the nukacin ISK-1 prepeptide, the modification enzyme, and the processing and transport protein respectively. Inactivation of nukA, nukM, or nukT resulted in a complete loss of nukacin ISK-1 production, implying that NukA, NukM, and NukT are indispensably involved in nukacin ISK-1 y To whom correspondence should be addressed. Fax: +81-92-642-3019; E-mail: sonomoto@agr.kyushu-u.ac.jp Abbreviations: ABC, ATP-binding cassette; PCR, polymerase chain reaction; SPR, surface plasmon resonance biosynthesis. 19) Here we report on an interaction analysis of the nukacin ISK-1 biosynthetic proteins NukA, NukM, and NukT. Our results suggest that NukM forms a multimeric complex with NukT and interacts with NukA for post-translational modification of nukacin ISK-1 at the cytoplasm membrane. This is the first report of the localization and interaction of proteins involved in posttranslational modification in type-A(II) lantibiotics.
Materials and Methods
Bacterial strains, media, and plasmids. Staphylococcus carnosus TM300 20) and Escherichia coli JM109 were grown at 37 C in LB medium. Escherichia coli BL21 (DE3) was grown at 37 C in 2 Â YT medium.
21)
Saccharomyces cerevisiae EGY48 (MAT trp1 his3 ura3 leu2::6 LexAop-LEU2) was grown at 30 C in YPD liquid medium (20 g/l Bacto peptone, 20 g/l glucose, 10 g/l yeast extract). Recombinant Sc. cerevisiae was selectively grown on a synthetic medium 22) supplemented with the required amino acids. Ampicillin (50 mg/ml) and tetracycline (25 mg/ml) were used for the selection of E. coli and St. carnosus transformants respectively. The plasmid pET-14b was used for expression of the recombinant proteins in E. coli BL21 (DE3). The plasmid pTX15 was used for expression of NukM in St. carnosus TM300. The plasmids pEG202 and pJG4-5 were used for expression of the fusion proteins containing the LexA-binding domain and the LexA-activation domain respectively, in Sc. cerevisiae EGY48.
Molecular biology protocols.
Plasmids from E. coli were isolated with a Mag Extractor plasmid extraction kit (Toyobo, Osaka, Japan). Transformation of St. carnosus TM300 was performed according to the method described by Peschel et al. 20) General molecular biology techniques were carried out following established protocols. Purified fusion proteins were resuspended in 20 mM phosphate buffer (pH 8.0) containing 1% SDS and then used for immunization of rabbits. New Zealand white rabbits were injected subcutaneously with 1 mg of fusion proteins that were emulsified in Freud's complete adjuvant. The antisera were collected after four booster injections at 1-week intervals (KBT Oriental, Saga, Japan). Pre-immune sera were taken from each rabbit before immunization.
Preparation of membrane vesicles. Membrane vesicles of St. warneri ISK-1 were prepared by the method described for Streptococcus cremoris.
23) Cells (OD 600 ¼ 5:0) from the 200-ml cultures were harvested by centrifugation (6;000 Â g, 15 min, 4 C) and then washed with 30 ml of 100 mM Tris-HCl buffer (pH 8.0). The cells were suspended in 6 ml of the same buffer and then treated with 0.1 g/l of lysostaphin (Seikagaku, Tokyo, Japan) at 37 C for 30 min for cell lysis. Three M NaCl (final concentration, 0.5 M) was added to the lysed cells and the solution was diluted immediately with 14 ml of 100 mM Tris-HCl buffer (pH 8.0). After centrifugation (6;000 Â g, 20 min, 4 C), sediment containing intact cell and cell debris was removed. Membrane and cytoplasm fractions were separated by ultracentrifugation (125;000 Â g, 1.5 h, 4 C). Membrane vesicles were washed twice with 100 mM Tris-HCl buffer (pH 8.0), and stored at À80 C.
Yeast two-hybrid assay. To observe the interactions among biosynthetic proteins involved in nukacin ISK-1 maturation, yeast two-hybrid assay 24, 25) was carried out using the DupLEX-AÔ yeast two-hybrid system (OriGene Technologies, Rockville, MD). DNA fragments of nukA, nukM, and nukT were amplified by PCR and then digested with appropriate restriction enzymes. The digested fragments were cloned into the plasmids, pEG202 and pJG4-5, encoding the LexA-binding domain and the LexA-activation domain respectively. The sets of resulting plasmids were co-introduced into Sc. cerevisiae EGY48 harboring the lacZ reporter gene containing the upstream region of the LexA-binding site according to the manufacturer's protocols. Subsequently, the resulting transformants were assayed forgalactosidase activity.
-Galactosidase assay. To evaluate the interactions between the two proteins, -galactosidase colony lift filter assays were carried out according to the manufacturer's protocols (yeast protocols handbook, Clontech). Yeast transformants transferred to sterile filters were freeze-thawed into liquid nitrogen. The filters with permeabilized cells were placed, keeping the colony side up, on filters presoaked with a Z buffer-X-Gal solution (25 ml of Z buffer [60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 , pH 7.0], 70 ml of -mercaptoethanol, 420 ml of X-Gal solution [100 mg of 5-bromo-4-chloro-3-indolyl--D-galactopyranoside in 1 ml of N,N-dimethylformamide]), and the colors of the colonies were then checked.
SDS-PAGE and Western blot analysis. Proteins were separated on Tris/glycine gels by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie Brilliant Blue. Low molecular weight markers were used as standards (Amersham Bioscience). Western blot analysis was performed to locate the proteins on SDS-PAGE. NukM and NukT were detected by anti-NukM and anti-NukT antisera respectively. Immunoreactive proteins were visualized with an enhanced chemiluminescence plus kit (Amersham Bioscience).
Expression of NukM in St. carnosus TM300 and membrane preparation. The gene fragment of nukM was amplified by PCR with the following set of primers:
0 . The amplified fragment was cloned into pTX15 at the BamHI and NarI sites. The resulting plasmid, pTXnukM, was introduced into St. carnosus TM300. The resulting strain, St. carnosus TM300 (pTXnukM), was cultured in LB broth supplemented with 0.5% xylose for 18 h. The cells were harvested, washed in 100 mM Tris-HCl buffer (pH 8.0), and disrupted with glass beads in 100 mM Tris-HCl buffer (pH 8.0) using a multi bead shocker MB-200 (Yasui Kikai, Osaka, Japan). The membrane and cytoplasm fractions were prepared as described above.
Expression and purification of NukA. The gene fragment of nukA was amplified by PCR with the following set of primers: 5 0 -TTTAGGAGGATCCAAA-CATGGAAAA-3 0 and 5 0 -TATTAAGGATCCAATAC-TCTCCA-3 0 . The amplified fragment was cloned into pET-14b at the BamHI site. The resulting plasmid, pETnukA, was introduced into E. coli BL21 (DE3). NukA was overexpressed as a His-tagged fusion protein, His-NukA, by induction with IPTG at a final concentration of 1 mM for 3 h at 37
C. The cells were harvested and then disrupted by sonication. His-NukA was expressed as a soluble protein and purified with HiTrap Chelating HP (Amersham Bioscience).
SPR biosensor analysis. A Biacore biosensor 1000 (BIAcore AB, Uppsala, Sweden) was used to analyze the interaction between NukA and NukM. SPR assay was performed at 37 C in HBS buffer (10 mM HEPES, 150 mM NaCl, pH 7.4). Sensor chip nitrilotriacetic acid (NTA) (BIAcore AB) activated by Ni 2þ was used to immobilize His-NukA via a His-tag. Prior to immobilization of His-NukA, the sensor chip was activated with 500 mM of NiCl 2 in HBS buffer at a flow rate of 10 ml/ min for 1 min. NiCl 2 equivalent to 30 resonance units (RU) was immobilized. Purified His-NukA solution (200 nM) was passed over the Ni 2þ -NTA surface at a flow rate of 10 ml/min for 20 min. His-NukA equivalent to approximately 40 RU was immobilized via His-tag. Each 50 mg-protein/ml of crude extract and membrane fraction of St. carnosus TM300 harboring pTXnukM was passed over the sensor chip with immobilized HisNukA at a flow rate of 5 ml/min for 7 min. Crude extract of St. carnosus TM300 harboring pTX15 was used as a control. Subsequently, HBS buffer was injected at a flow rate of 5 ml/min for 3 min to monitor the dissociation of NukA-NukM complex. Data analysis of all sensorgrams was carried out using BIAevaluation 2.1 software (BIAcore AB). The specific binding profile of NukM to the immobilized His-NukA was obtained after subtracting the response signal of the control from the observed one.
Results and Discussion

Localization analysis of NukM and NukT in St. warneri ISK-1
We examined the localization of NukM and NukT in St. warneri ISK-1. Western blot analysis with specific anti-NukM and anti-NukT antisera showed that signals corresponding to NukM (106 kDa) and NukT (80 kDa) occurred in the membrane fraction but not in the cytoplasm fraction (Fig. 1A) . This result clearly indicates the presence of NukM and NukT at the cytoplasm membrane and also suggests that nukacin ISK-1 maturation would occur at the cytoplasm membrane since it was found in type-A(I) lantibiotics. 20, 26, 27) Expression and localization analysis of NukM in St. carnosus TM300 Consideration of codon usage and therefore to obtain high expression, we demonstrated the expression of NukM in St. carnosus TM300. NukM overexpressed in St. carnosus TM300 was analyzed by SDS-PAGE. The band corresponding to NukM (106 kDa) was detected in the transformant harboring the pTXnukM but not in the control with plasmid pTX15 (data not shown). Moreover, localization analysis of NukM overexpressed in St. carnosus TM300 was also performed by Western blot analysis. As shown in Fig. 1B , the signal corresponding to NukM was detected in the membrane fraction, indicating that NukM was located at the cytoplasm membrane even without NukT. No localization change of NukM in St. carnosus TM300 was observed by any of the methods for membrane preparation using osmotic burst and glass beads (data not shown). The hydrophobic profile of NukM by the SOSUI 28) and DAS 29) programs suggested the absence of transmembrane segments and therefore indicated that NukM was independently associated with the cytoplasm membrane.
Interaction analysis of NukA, NukM, and NukT by the yeast two-hybrid assay
The sequence alignment of LanM in type-A(II) lantibiotics with LanC in type-A(I) lantibiotics showed that the C-terminal part of LanM had sequence similarities with LanC.
30) The C-terminal part (positions 480-917) of NukM contains the homologous region to LanC protein. Hence the N-terminal part (positions 1-581) and the C-terminal part (positions 480-917) were selected for interaction analysis. In the case of NukT, three domains, the cysteine protease domain (positions 1-150), the membrane-spanning domain (positions 155-425), and the ATP-binding domain (positions 490-666) were found to be similar to other LanT in type-A(II) lantibiotics. 31) Therefore we selected three parts of NukT, the N-terminal part (positions 1-112), the middle part (positions 97-450), and the C-terminal part (positions 451-694) for the interaction analysis. We analyzed the interactions between proteins of NukA, two parts and the complete form of NukM, and three parts of NukT. Protein-protein interactions were monitored by the result of -galactosidase activity (Table 1) .
First we observed that both terminal parts and the complete form of NukM interacted with NukA. In case of the interaction between NukA and the N-terminal part of NukM, the reciprocal fusions of LexA activation and the binding domain showed opposite results. But such interactions were reported and judged without invalidating the positive result. 25, 30) Our results coincide with the results reported by Uguen et al., 30) except that they found no interaction between lacticin 481 prepeptide and the truncated derivatives of the LanM protein LctM. NisA and NisC, which are the LanA and LanC proteins for nisin respectively, have been shown to interact with each other. 11) In addition, we examined the interaction between NukA and NukT as well as the interaction between NukM and NukT. NukA interacted with the Nterminal and the middle part of NukT but not with the Cterminal part. Interactions of the C-terminal part of NukM with the middle and the C-terminal part of NukT were also observed. From these results, we propose that NukA, NukM, and NukT interact with each other (Fig. 2) . The yeast two-hybrid assay also allowed us to test for self-interactions of NukA, NukM, and NukT. Self-interaction of the C-terminal part of NukM and the middle part of NukT were observed. This result implies that NukM and NukT molecules formed at least a dimer. However, we have no evidence for dimerization of NukM and NukT in the present study.
Based on the results obtained in this study, we propose that two or more NukM and NukT molecules form a complex at the cytoplasm membrane, and that nukacin ISK-1 maturation occurs by a membranelocated multimeric protein complex. This is the first report focused on the localizations and interactions of the lantibiotic prepeptide LanA, the modification enzyme LanM, and the dual-functional ABC transporter LanT in the type-A(II) lantibiotics. In vitro interaction analysis between NukA and NukM by SPR biosensor
We determined the interaction between NukA and NukM in vitro by SPR biosensor. Crude extract of St. carnosus TM300 harboring pTXnukM showed higher response units (102 RU) than that of the control (50 RU) (Fig. 3A) . NukM was not observed to bind to the sensor chip without NukA (data not shown). The specific interaction between immobilized NukA and NukM (52 RU) was obtained upon substraction of the non-specific signal by the control from the observed one (Fig. 3B) . This result indicates that NukM interacts specifically with NukA. We determined the kinetic parameters of NukA-NukM binding from the sensorgram of Fig. 3B À8 M). The sensorgrams and the binding amount (102 RU) of crude extract and membrane fraction were almost the same (Fig. 3C) . This result strongly supported our yeast two-hybrid assay, and hence suggested that the membrane-located NukM interacted with NukA. Recently, in vitro reconstitution of lantibiotic-synthetase activity using only LctM has been reported. 12) Our SPR analysis also implied that NukM independently recognized NukA without complex formation with NukT. Hence we propose that NukM and NukT form a well-governed complex for the efficient production of nukacin ISK-1 to prevent the diffusion-controlled state of the substrate in active cells. This study provide the first knowledge of the membranelocated post-translational modification system composed of NukM and NukT in the type-A(II) lantibiotics, nukacin ISK-1. The numbers in parentheses indicate the positions of amino acid residues in each protein. , interaction; , no interaction. The interactions between two proteins were evaluated by -galactosidase colony lift filter assay in accordance with the manufacturer's protocols (yeast protocols handbook, Clontech). Blocks with the positions of amino acid residues represent the parts of NukA, NukM, and NukT used for interaction assay. Solid arrows indicate intermolecular interaction, and broken arrows indicate intramolecular interaction. His-NukA (40 RU) was immobilized via His-tag on a sensor chip activated with NiCl 2 . The relative response units (RU) were plotted against time. A, SPR sensorgrams obtained using crude extracts (50 mg-protein/ml) from St. carnosus TM300 (pTXnukM) ( ) and St. carnosus TM300 (pTX15) ( ). The arrows indicate the binding amount after dissociation. B, NukM-binding curve generated by substraction of the sensorgram of St. carnosus TM300 (pTX15) from that of St. carnosus TM300 (pTXnukM). The arrow indicates the specific binding amount of NukM to immobilized NukA. C, SPR sensorgrams obtained from crude extract ( ) and membrane fraction ( ) of St. carnosus TM300 (pTXnukM). Each 50 mgprotein/ml of crude extract and membrane fraction was passed over the sensor chip with immobilized His-NukA. The arrow indicates the binding amount after dissociation.
